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Abstract  
Investigations were carried out on the association between some reproductive hormones (Progesterone, 
oestrogen, leutenizing and follicle stimulating hormones), and fibroid cases in Nigerian women.  The levels of 
these hormones were determined in 30 patients with chronic fibroid cases and another 30 patients with non 
chronic fibroid cases. The mean values of these hormones in non-chronic fibroid cases (14.50±0.20, 98.01±0.67, 
0.51±0.05, 4.02±0.74 respectively), were found  to be significantly higher than corresponding values in non 
fibroid cases. Also the values obtained in chronic fibroid cases were also significantly higher (P<0.05) than that 
of the non chronic fibroid cases. Our finding indicates that the alteration in these reproductive hormone levels 
might be related with the pathogenesis of fibroid in Nigerian women. 
Keywords: reproductive hormones, progesterone, oestrogen, leuteinizing hormones, follicle stimulating 
hormones, fibroid, pathogenesis. 
 
INTRODUCTION 
 A uterine fibroid is a leionyoma (benign, non cancerous tumor form of smooth muscle tissue, that 
originates from the smooth muscle layer (myometrium) of the uterous. Fibroids are often multiple.  The 
malignant version of a fibroid is extremely uncommon and termed leiomyosercoma (Neigeret et al,2006) 
 Fibroids are the most common benign tumors in females and typically found during the middle and later 
reproductive years. While most fibroids are asymptomatic, they can grow and cause heavy and painful 
menstruation, painful sexual intercourse, and urinary frequency although these appear to be very rare (Neigeret 
et al, 2006). Symptoms caused by uterine fibroid are  a very frequent indication for hysterectomy (Neimanetal 
2011; ApplezWeig, 2006)  
 Uterine fibroids are large masses made up of tissue cells from uterus, actually a type of non cancerous 
tumor, fibroids can grow in and around  uterus distorting the shape and size of this organ. Fibroids typically 
range in size, from few centimeters to up to 15 centimeters or more. Fibroid tumors often grow in clusters, so if a 
person has one uterine fibroid it is likely the person develop another (Akinyemi et al, 2004; Fisher et al 2010) 
 Uterine fibroid can affect women at any age, however women between ages 20 and 50 are likely to 
develop larger fibroids.  
 Reproductive hormones generally are connected with fibroid   growth. Hormones are chemical 
substance secreted by one tissue and travels by way of body fluids to affect another tissue in the body. In essence 
they are chemical messengers (Shozu et al , 2004, Whitehead and Nuzzey 2001). Fibroid growth is strongly 
dependent on reproductive hormones such as oestrogen, progesterone, follicle stimulating hormones, luteinizing 
hormones etc 
 The growth of fibroid has been associated with oestrogen during reproductive years (Cesen – 
cunmmings et al 2003). Elevated follicle stimulating hormones receptor levels have been detected in the 
endothelia of tumor vasculature in a very wide range of solid tumor (Rokola 2008). Oestrogen and progesterone 
which are major hormones which aid the growth of fibroids, are both secreted by the reproductive activity of 
luteinizing hormones together with that of follicle stimulating hormones, therefore relevant only during 
reproductive years. (Evans and Brunsell, 2007)  
 The increased occurrence of uterine fibroid among women especially in Nigeria has prompted the 
current research work. 
 
MATERIALS AND METHOD 
Grouping  
 The present study was carried out at Ekiti State University teaching Hospital (EKSUTH) Ado Ekiti, 
Ekiti State Nigeria. The study included patients without the history of fibroid, (Non fibroid). Patients who have 
just been discovered by accident with fibroid (Non chronic fibroid), and patient with chronic fibroid cases who 
are advised to go through operation (chronic fibroid).  All the patients were attending antenatal clinics in out 
patients department (OPD) of EKSUTH. All the patients were ranging 20-50 years. The subjects were divided 
into three groups. 
Group 1 included twenty subjects of patients with no record of uterine fibroid that serve as controls. Group 2 is 
made up of twenty patients with non chronic fibroid cases while group 3 is made up of another twenty patients 
with chronic fibroid cases. 
Blood sampling 
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Blood samples were drawn from all the subjects following a fast of 6-12 hours. Plasma was separated by 
centrifuging the blood at 3000rpm for 10minutes at 40c. The plasma was used for the estimation of progesterone, 
oestrogen, follicle stimulating hormone and lentenizing hormone. 
Biochemical assay  
 All the reproductive hormones assayed for were estimated by the method of enzyme linked 
immnosorbent assay (ELISA) .  
Statistical Analysis  
Data got from the presents study were presented as mean value ± SD. The statistical significance was evaluated 
by students “T” test  
 
RESULT AND DISCUSSION  
TABLE 1: Clinical characteristics of the study groups   
 
Characteristics                  NFP                  NFCP                CFP                  P-Value 
Number of women            20                     20                   20                    NS     
Age (Years)                       28.0±4.20         37.7±5.51       41.0±3.20       P<0.05 
Weight (Kg)                      52.5±2.02         69.0 ± 4.10     74.5±2.10       P<0.05 
Height (ft)                         5.2±4.02           5.1±3.80         5.3±4.00          NS 
 
 
TABLE 2: Reproductive Hormones in non fibroid patients, non-chronic fibroid patients and chronic fibroid 
patients. 
 
Parameters                                                  NFP                 NCFP                CFP 
Oestrogen (mmol/ml)                               88.1±2.02       96.3±1.40        98.0±1.67 
Follicle Stimulating Hormone (ng/ml)    3.19±2.40        3.51±7.04       4.02±7.04 
Progesterone (mmol/L)                             12.40±0.21     13.95±0.20      15.51±0.20 
Leuteinizing Hormone (mmol/L)             0.30±0.10        0.51±0.03        0.55±0.05 
 
*P-Value <0.05 
NFP –   Non Fibroid Patient 
NCFP- Non Chronic Fibroid Patient 
CFP-     Chronic Fibroid Patient 
 
            Characteristics of the non fibroid women, non chronic fibroid women and chronic fibroid women are 
summarized in table 1. There were insignificant differences between the groups as regarding number of women 
and height. However significantly higher values were found for age and weight.   
 Considering the level of progesterone, it was found be significantly highest in chronic fibroid women 
while the level in non fibroid women while the level in non fibroid women is significantly lower than  that of 
non chronic fibroid hormones. Biochemically, fibroids have higher progesterone receptor concentrations than 
normal myometrium, this suggest that progesterone enhances fibroid growth (Gold -zieher et al 2006, Ross et al 
2006, Marshall et al 2007). 
    For oestrogen, women with chronic fibroid and non chronic fibroid showed significant increase level 
compared to non fibroid women. Oestrogen promotes the growth of fibroid (Neigere al 2006, Cesen- 
cummings et al 2003). One of the reasons why there can be increase in the levels of oestrogen as the fibroid 
grows can be as a result of increase in weight of the women. Oestrogen can be synthesized by fat cells (Nelson 
and Buchin 2001, Anate, 2007)  
 Women with chronic fibroid showed significantly higher value in follicle stimulating hormones 
compared to non chronic fibroid and non fibroid women . The increase in the level of  FSH  may be as a result of 
the increase in some level of progesterone and oestrogen which no higher suppress the release of follicle 
stimulating hormones (Dickerson et al 2008).  Also in females generally, at the end of the initial phase there is a 
slight rise in follicle stimulating that seems to be of importance to start the next ovulatory cycle (Fowler et al 
2003). 
 It was also found that there was a significant increase in the level of luteinizing hormone in chronic 
fibroid women and non chronic fibroid women. One of the reasons why luteinizing hormone may have such 
significant increase is that, the release of luteinizing hormone at the pituitary gland is controlled by pulses of 
gonadotropin-releasing hormones (GnRH) from the hypothalamus. Those pulses in turn are subject to extugen 
feedback by the gonads,  so a spike in oestrogen production stimulates the release of luteinizing hormone 
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(Boynton et al 2005;  Wallach and Vlahos 2004).  
 The significant increase in the level of all the reproductive hormones examined in this study as fibroid 
progresses from non chronic to chronic state may be an indication that reproductive hormones changes is a 
contributory factor to fibroid in women. 
Conclusion 
 From our results, it is evident that all the levels of the reproductive hormones considered are 
significantly higher in fibroid cases. Thus we conclude that fibroid in women is associated with changes in 
reproductive hormones levels in Nigerian women. 
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